NASDAQ: ERASErasca Inc Stock Ownership - Who owns Erasca?
Insider buying vs selling
Have Erasca Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David M. Chacko | CFO and CBO | 2023-12-15 | 7,478 | $1.59 | $11.88kBuy |
| Ebun Garner | General Counsel Corp. Sec. | 2023-12-15 | 5,448 | $1.59 | $8.66kBuy |
| Valerie Denise Harding Start | Director | 2023-12-06 | 10,000 | $1.85 | $18.48kBuy |
| Jonathan E. Lim | Chairman CEO | 2023-12-06 | 278,150 | $1.72 | $478.42kBuy |
| Jonathan E. Lim | Chairman CEO | 2023-12-05 | 721,850 | $1.69 | $1.22MBuy |
| Alexander W. Casdin | Director | 2023-12-04 | 30,000 | $1.66 | $49.77kBuy |
| Jonathan E. Lim | Chairman CEO | 2023-10-05 | 1,000,000 | $2.03 | $2.03MBuy |
| Jonathan E. Lim | Chairman CEO | 2023-06-08 | 100,000 | $2.75 | $275.00kBuy |
ERAS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ERAS insiders and whales buy or sell their stock.
ERAS Shareholders
What type of owners hold Erasca Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jonathan E. Lim | 41.22% | 62,451,152 | $118.03M | Insider |
| Arch Venture Partners X LLC | 7.30% | 11,055,554 | $20.89M | Insider |
| Arch Venture Management LLC | 7.30% | 11,055,554 | $20.89M | Institution |
| Bihua Chen | 7.14% | 10,813,246 | $20.44M | Insider |
| Armistice Capital LLC | 5.34% | 8,096,000 | $15.30M | Institution |
| Blackrock Inc | 4.83% | 7,310,321 | $13.82M | Institution |
| Artal Group Sa | 3.12% | 4,721,194 | $8.92M | Institution |
| Vanguard Group Inc | 2.50% | 3,792,343 | $7.17M | Institution |
| Ah Capital Management LLC | 1.89% | 2,862,500 | $5.41M | Institution |
| Pfm Health Sciences LP | 1.70% | 2,575,511 | $4.87M | Institution |
ERAS vs Biotech Stocks
Erasca Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.